RegoMel: A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma (clinicaltrials.gov) - Oct 1, 2026 - P2 | N=48 | Active, not recruiting | Sponsor: Universitair Ziekenhuis Brussel | Trial completion date: Mar 2025 ➔ Mar 2027 | Trial primary completion date: Dec 2024 ➔ Dec 2026 | Recruiting ➔ Active, not recruiting
Enrollment closed • Trial completion date • Trial primary completion date • Melanoma • Oncology • Solid Tumor • PD-L1
|